AGP Executive Report
Last update: 12 hours agoInnovative Medicine Access in Bulgaria: EFPIA’s WAIT indicator shows a drop in access to newly approved therapies: only 46% of new EU medicines reached Bulgaria in 2021–2024, down from 53% in 2020–2023, with industry warning that pricing and reimbursement reforms are urgently needed. Public Health Watch: Measles cases in Bulgaria rose to 317 (Jan 1–May 24), compared with just one in the same period last year—an alert for vaccination and early care. Environmental Health & Air Quality: Greenpeace Bulgaria staged a “TOXIC” action at Bobov Dol thermal power plant, arguing coal operations harm health via sulphur dioxide and calling for limits and a shift to renewables. ALS Awareness: French actor Pierre Deny (69), known from “Emily in Paris,” died after a sudden and severe ALS battle—spotlighting a disease with no cure. Health Security & Outbreak Risk: WHO warns an Ebola outbreak in DRC is spreading faster than containment, with over 1,000 cases reported. Workforce & Care Needs: Bulgaria is allowing more third-country workers—28,000 in 2026 so far—amid shortages including in healthcare.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Bulgaria risks falling further behind on innovative medicine access [Advocacy Lab]](https://www.euractiv.com/content/uploads/sites/2/2026/05/GettyImages-944237458.jpg)
